Asia Pacific Protein Binding Assay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Equilibrium Dialysis, Ultracentrifugation, Ultrafiltration, Surface Plasmon, and Others) and End User (Contract Research Organization, Pharmaceutical & Biotechnology Companies, and Research & Diagnostic Laboratories)

Market Introduction

Asia Pacific includes countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. This region accounted for being fastest-growing region of the global protein binding assay market in 2019 owing to substantial number of CROs operating in the space; growing pressure to reduce drug discovery and development costs; growing healthcare expenditure; increase in developments in the pharmaceutical and biotechnological industries in India and China; expanding research base across India, China, and Japan; and increasing pharmaceutical R&D expenditure. In the Asia Pacific region, China is the largest market for protein binding assay. The growth of the market is primarily attributed to several new discoveries driven by research & development and rising number of clinical trials in the country. The growth of the market is attributed to the increasing R&D activities, rising investments in the healthcare sector in developing countries, and increasing collaborations between regulatory outsourcing and drug developers. As per the Government of China in January 2018, China's 13th five-year plan stipulates that biotechnology sector is expected to exceed around 4% of gross domestic product by 2020. Also, China has more than 100 life science parks and approx. USD 100 billion has already been invested by Chinese government to promote biotechnology. In December 2018, PAREXEL, a leading innovator in global biopharmaceutical services, announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China. The program will provide high-value training opportunities for Chinese clinical trial sites and investigators, enhance local clinical trials, and drive innovation in China's biopharmaceutical industry. To encourage innovation in drug development, the Chinese government has recently launched a series of new policies for clinical research, resulting in a sharp increase in the number of clinical trials in China. According to China's clinical trial registration platform, 1,258 drug clinical trials were first registered and published in China in 2017, an increase of 62.66% compared to 2016. A recent report indicates that the total number of class 1.1 chemical drugs and class 1 biologic drugs approved for clinical trials from January to October 2017 was three times that of 2014. However, the number of GCP-qualified clinical trial sites did not increase significantly between 2014 and 2016. In 2017, China implemented sweeping reforms to its regulatory system, closely aligning the rules governing the world's second-largest drug market with the US and Europe. The result was a sharp rise in applications by Chinese biotech companies to register innovative therapies in the US. IND filings jumped from 11 in 2016 to 20 in 2017 and almost doubled again with an additional 38 applications in 2018 and the first quarter of this year. Chinese policy changes also prompted Western firms to tap China's much larger patient pool to simultaneously access high-quality clinical data to support US registration and, around the same time, to gain rapid registration in China. The increasing adoption of protein binding assays in drug discovery & development offering lucrative opportunities for the protein binding assay market

According to Worldometer, from its epicenter in China, SARS-CoV-2 has spread to infect ~58,231,688 people in Asia, as of July 29, 2021. Following the terrible loss of lives, economies in Asia Pacific have collapsed during the pandemic. The pandemic has emphasized health data exchange and interoperability under a microscope. The supply chain disruptions, along with the tremendous demand for efficient treatments against COVID-19, have put the healthcare research industry in a crucial situation in region. Socioeconomics in countries such as India, China, Japan, and South Korea were severely affected, resulting in rise in inflation, decrease in GDP, and surge in unemployment. Countries such as China, Japan, Singapore, and South Korea show large interest in clinical trials. High costs in western countries drives the flow of medical affairs outsourcing to Asia Pacific. Moreover, pharmaceutical companies are becoming aware of new and changing regulatory environments for drugs, devices, and in vitro diagnostics to expand sales to the Asian market. Asian countries have been at a forefront of updating GMP standards and medical device regulatory systems and introducing drug price controls. Third-party guidance and advice are required as part of any acquisition or any improvement of current standards. Increasingly, third-party outsourcing service providers are playing a greater role in supporting the protein binding assay market progress in Asia Pacific.

Get more information on this report :

Market Overview and Dynamics

The protein binding assay market in APAC is expected to grow from US$ 73.34 million in 2021 to US$ 153.72 million by 2028; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028. Rising pressure to reduce drug discovery and development costs; the cost of developing new drugs remains high at an inflation-busting rate, and returns and profits on investments are declining, placing pressure on the entire innovative medicine system. Many research-based pharmaceutical and biopharmaceutical companies are reevaluating old R&D policies and focusing their efforts on improving efficiency, increasing output, and satisfying unmet patient requirements due to current economic and political pressures to reduce the healthcare cost. The changing focus on drug discovery and development, and the rising use of new technologies for identifying and screening drug candidates create new opportunities to target various chronic, degenerative, and life-threatening diseases that were previously untargeted. The process of discovering and developing a drug is costly, as it requires investments in funding, human resources, and technologies. Before launching a new drug in the market, strict adherence to regulations on testing and manufacturing standards is required. Furthermore, if a drug candidate fails during the development stage, the entire investment gets wasted. Protein binding studies aid in the optimization of drug discovery expenses by assessing binding and absorption capabilities in preclinical phases, resulting in lower drug attrition in the late stages of development. Thus, rising pressure to reduce drug discovery and development costs driving the market growth.

Key Market Segments

Based on technology is segmented into ultracentrifugation ultrafiltration, equilibrium dialysis, surface plasmon and others. In 2020, the equilibrium dialysis segment is likely to hold the largest share of the market, by technology. Based on the end user was segmented into contract research organization, pharmaceutical & biotechnology companies, and research & diagnostic laboratories. In 2020, the pharmaceutical & biotechnology companies segment is likely to hold the largest share of the market, by end user.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the protein binding assay market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Biotium, Inc, Eurofins Scientific, General Electric Company, MERCK KGaA, MicroConstants, Inc, Pharmaron Beijing Co., Ltd, Sartorius AG, SOVICELL GMBH, and THERMO FISHER SCIENTIFIC INC. among others.

Reasons to buy report

To understand the APAC protein binding assay market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC protein binding assay market
Efficiently plan M&A and partnership deals in APAC protein binding assay market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC protein binding assay market
Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC PROTEIN BINDING ASSAY MARKET SEGMENTATION

By Technology

Equilibrium Dialysis
Ultracentrifugation
Ultrafiltration
Surface Plasmon
Others

By End User

Contract Research Organization
Pharmaceutical and Biotechnology Companies
Research and Diagnostic Laboratories

By Country

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Protein Binding Assay Market – By Technology

1.3.2 APAC Protein Binding Assay Market – By End User

1.3.3 APAC Protein Binding Assay Market– By Country

2. APAC Protein Binding Assay Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Protein Binding Assay Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific – PEST Analysis

4.3 Experts Opinion

5. APAC Protein Binding Assay Market – Key Market Dynamics

5.1 Drivers

5.1.1 Surge in Drug Discovery Activities and pharmaceutical R&D expenditure

5.1.2 Rising Pressure to Reduce Drug Discovery and Development Costs

5.2 Market Restraints

5.2.1 Challenges with Existing Technologies

5.3 Market Opportunities

5.3.1 Rising CRO Industry in Emerging Markets

5.4 Future Trends

5.4.1 Label-Free Receptor Assays to Emerge as Powerful Assay Platform in Coming Years

5.5 Impact Analysis

6. Protein Binding Assay Market– APAC Analysis

6.1 APAC Protein Binding Assay Market Revenue Forecast and Analysis

7. APAC Protein Binding Assay Market Analysis and Forecast to 2028 – Technology

7.1 Overview

7.2 APAC Protein Binding Assay Market Share by Technology 2021 & 2028 (%)

7.3 Equilibrium Dialysis

7.3.1 Overview

7.3.2 Equilibrium Dialysis: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Ultracentrifugation

7.4.1 Overview

7.4.2 Ultracentrifugation: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Ultrafiltration

7.5.1 Overview

7.5.2 Ultrafiltration: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Surface Plasmon

7.6.1 Overview

7.6.2 Surface Plasmon: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

7.7 Others

7.7.1 Overview

7.7.2 Others: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

8. APAC Protein Binding Assay Market Analysis and Forecast to 2028 – End User

8.1 Overview

8.2 APAC Protein Binding Assay Market Share by End User 2021 & 2028 (%)

8.3 Contract Research Organization

8.3.1 Overview

8.3.2 Contract Research Organization: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Pharmaceutical and Biotechnology Companies

8.4.1 Overview

8.4.2 Pharmaceutical and Biotechnology Companies: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Research and Diagnostic Laboratories Market

8.5.1 Overview

8.5.2 Research and Diagnostic Laboratories: APAC Protein Binding Assay Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Protein Binding Assay Market – Country Analysis

9.1 Asia Pacific: Protein Binding Assay Market

9.1.1 Overview

9.1.3 Asia Pacific: Protein Binding Assay Market, by Country, 2021 & 2028 (%)

9.1.3.1 Japan: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Japan: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Japan: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.1.3 Japan: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

9.1.3.2 China: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 China: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 China: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.2.3 China: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

9.1.3.3 India: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1 India: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2 India: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.3.3 India: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

9.1.3.4 South Korea: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1 South Korea: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2 South Korea: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.4.3 South Korea: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

9.1.3.5 Australia: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1 Australia: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2 Australia: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.5.3 Australia: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

9.1.3.6 Rest of Asia Pacific: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1 Rest of Asia Pacific: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2 Rest of Asia Pacific: Protein Binding Assay Market, by Technology, 2019–2028 (USD Million)

9.1.3.6.3 Rest of Asia Pacific: Protein Binding Assay Market, by End User, 2019–2028 (USD Million)

10. APAC Protein Binding Assay Market– Industry Landscape

10.1 Overview

10.2 Developments

10.2.1 Overview

11. Impact Of COVID-19 Pandemic on APAC Protein Binding Assay Market

11.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 THERMO FISHER SCIENTIFIC INC.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 MERCK KGaA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Eurofins Scientific

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 General Electric Company

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 SOVICELL GMBH

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Pharmaron Beijing Co., Ltd.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Biotium, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 MicroConstants, Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Sartorius AG

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Number of Registered Studies for Clinical Trials

Table 2. Top 10 Pharmaceutical R&D Spenders, 2019

Table 3. APAC Protein Binding Assay Market – Revenue and Forecast to 2028 (US$ Million)

Table 4. Japan: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 5. Japan: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7. China: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. India: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 9. India: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10. South Korea: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11. South Korea: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. Australia: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 13. Australia: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Rest of Asia Pacific: Protein Binding Assay Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15. Rest of Asia Pacific: Protein Binding Assay Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 16. Developments Done by Companies

Table 17. Glossary of Terms, Protein Binding Assay Market

LIST OF FIGURES

Figure 1. APAC Protein Binding Assay Market Segmentation

Figure 2. APAC Protein Binding Assay Market Segmentation, By Country

Figure 3. APAC Protein Binding Assay Market Overview

Figure 4. Equilibrium Dialysis Segment Held the Largest Share by Technology Segment in APAC Protein Binding Assay Market

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. Asia Pacific PEST Analysis

Figure 7. APAC Protein Binding Assay Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. APAC Protein Binding Assay Market Share by Technology 2021 & 2028 (%)

Figure 9. Equilibrium Dialysis: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 10. Ultracentrifugation: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Ultrafiltration: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Surface Plasmon: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Others: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Protein Binding Assay Market Share by End User 2021 & 2028 (%)

Figure 15. Contract Research Organization: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Pharmaceutical and Biotechnology Companies: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Research and Diagnostic Laboratories: APAC Protein Binding Assay Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Asia Pacific: Protein Binding Assay Market, by Key Country – Revenue (2021) (USD Million)

Figure 19. Asia Pacific: Protein Binding Assay Market, by Country, 2021 & 2028 (%)

Figure 20. Japan: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 21. China: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 22. India: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 23. South Korea: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. Australia: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Rest of Asia Pacific: Protein Binding Assay Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

Site License

$4000

Enterprise License

$5000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample